Surgical Hemostats Market Size & Share, by Hemostats Type (Topical thrombin-based, Flowable, Collagen-based, Oxidized Regenerated Cellulose-based, Gelatin-based, Combination); Formulation (Matrix & Gel, Sponge, Sheet & Pad, Powder); Application (General, Reconstructive, Cardiovascular, Orthopedic, Neurosurgery and Gynecological Surgery); End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5638
  • Published Date: Apr 25, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Surgical Hemostats Market size is projected to surpass USD 45 Billion by the end of 2036, growing at a CAGR of 12% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of surgical hemostats was USD 10 Billion. The escalating number of surgical procedures worldwide stands out as the primary catalyst propelling the growth of the surgical hemostats industry. In recent years, there has been a notable surge in both elective and emergency surgeries, contributing to an augmented need for effective hemostatic solutions since they are crucial in preventing excessive blood loss and ensuring a safe and successful surgery. According to a report by the World Health Organization (WHO), the global volume of surgical procedures is poised to exceed 300 million annually.

In addition, factors that are believed to fuel the market expansion of surgical hemostats include technological advancements. Innovations such as the development of hemostatic agents with improved clotting mechanisms and quicker onset times contribute significantly to patient outcomes. Surgeons increasingly favor these advanced technologies, appreciating their role in minimizing complications and enhancing overall surgical success rates.  A study highlighted that the adoption of advanced hemostatic technologies has resulted in a 25% reduction in postoperative bleeding complications across various surgical procedures.

Surgical Hemostats Market overview
Get more information on this report: Request Free Sample PDF

Surgical Hemostats Sector: Growth Drivers and Challenges

Growth Drivers

  • Burgeoning aging population- Elderly individuals often require surgical interventions for various health conditions, ranging from cardiovascular issues to orthopedic procedures. The prevalence of age-related ailments necessitating surgical treatment amplifies the demand for reliable hemostatic solutions. As healthcare systems adapt to address the needs of an aging demographic, the market for surgical hemostats is poised to witness sustained growth, aligning with the rising demand for surgical procedures among the elderly. According to the World Health Organization (WHO), the number of individuals 60 years of age and over will reach 2.1 billion worldwide by 2050.
  • Increasing prevalence of chronic diseases- Conditions such as cardiovascular disorders often require intricate surgical procedures where effective hemostasis is paramount. The incidence of chronic illnesses, coupled with advancements in medical diagnostics, leads to the identification of more cases necessitating surgical management.
  • Growing number of road accidents- An increase in traffic accidents has resulted in a spike in surgical procedures, which necessitates the usage of surgical hemostats since it is essential for emergencies in hospital settings. As per statistics, globally there were more than 11% more traffic accidents in 2022 than there were in 2021.


  • Exorbitant cost and need for skilled professionals - The high cost of hemostasis products is a result of the use of cutting-edge technology and the cost associated with acquiring qualified personnel may restrict the industry growth, particularly in areas with limited resources.
  • Risk of adverse complications can impact the market adoption of surgical hemostats- Despite being rare, there have been reports of potentially fatal side effects and complications with the use of resorbable hemostatic materials, such as gel foam, microfibrillar collagen, resorbable collagen since they run the risk of adhering to tissue and becoming infected, particularly if any portion of them is left unabsorbed.
  • Regulatory compliance may cause approval delays and may impede industry expansion

Surgical Hemostats Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 10 Billion

Forecast Year Market Size (2036)

USD 45 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Surgical Hemostats Segmentation

 End-Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)

The hospitals segment is expected to hold 50% share of the global surgical hemostats market by the end of 2036. The segment is flourishing as a result of the increasing integration of technology in healthcare practices. Modern hospitals are increasingly adopting advanced technologies such as robotic-assisted surgeries, image-guided interventions, and real-time monitoring systems.  Hospitals, as early adopters of these technologies, drive the demand for innovative surgical hemostats that complement and enhance these technological advancements. The integration of healthcare technologies is steadily increasing, with an annual growth rate of 15%.

Additionally, patient safety remains a paramount concern for hospitals, influencing the adoption of surgical hemostats. Effective hemostasis is a critical component of surgical care, with the potential to significantly reduce postoperative complications. Hospitals prioritize the use of hemostatic agents that contribute to positive patient outcomes by minimizing complications related to bleeding.

Formulation (Matrix & Gel, Sponge, Sheet & Pad, Powder)

The sheet & pad segment in the surgical hemostats market is set to garner a notable share shortly. Hemostat pads and sheets are multilayered materials with a self-adhering surface with a backing that resembles a sheet and are often used to regulate bleeding associated with surgery. 

In addition, a hemostatic sponge promotes tissue regeneration and has antibacterial and absorbent qualities, which have been utilized in dermatologic surgery to manage postoperative hemostasis resulting from low-pressure arteriolar, venous, and capillary bleeding.

Our in-depth analysis of the surgical hemostats market includes the following segments:

          Hemostats Type

  • Topical thrombin-based
  • Flowable
  • Collagen-based
  • Oxidized Regenerated Cellulose-based
  • Gelatin-based
  • Combination


  • Matrix & Gel
  • Sponge
  • Sheet & Pad
  • Powder


  • General Surgery
  • Reconstructive Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Gynecological Surgery


  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Surgical Hemostats Industry - Regional Synopsis

North American Market Forecast

The surgical hemostats market in the region is estimated to hold a share of about 35% by the end of 2036. The market growth in the region is due to the rising spending on healthcare. As a result, companies are spending more on technological innovations in healthcare, with a particular emphasis on advanced surgical techniques.  For instance, the amount spent on health care in the United States increased by around 4% in 2022 to over USD 3 trillion. The integration of robotic-assisted surgeries and other cutting-edge technologies necessitates specialized surgical hemostatic solutions. Surgeons increasingly rely on precise and efficient surgical hemostats to complement these innovations.

APAC Market Analysis

The Asia Pacific region will also encounter tremendous growth for the surgical hemostats market during the forecast period and will hold the second position owing to the rapidly growing population. With a significant proportion of the global populace residing in this region, there is a consequent increase in the demand for surgical interventions. As healthcare infrastructures expand and access to medical services improves, the number of surgeries performed in the Asia Pacific region rises, creating a substantial market for surgical hemostats to manage bleeding effectively in diverse surgical procedures.

Research Nester
Surgical Hemostats Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Surgical Hemostats Landscape

    • Ethicon, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Baxter International Inc.
    • Medtronic plc
    • B. Braun Melsungen AG
    • Pfizer Inc.
    • CryoLife, Inc.
    • C.R. Bard, Inc.
    • Integra LifeSciences Corporation
    • Z-Medica, LLC
    • Cardinal Health, Inc.

In the News

  • Baxter International Inc. a leading global MedTech company, announced the acquisition of Hillrom to expand its portfolio in the areas of acute treatments, surgical and critical care, and linked care, and to solidify the company's position as a top global MedTech provider.
  • Ethicon, Inc. obtained approval for ETHIZIA an adjunctive hemostat solution with a unique design that surgeons can rely on to function as well on both sides and is made for maximum versatility and gives them the confidence they need in every surgical scenario.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5638
  • Published Date: Apr 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of surgical hemostats was over USD 10 billion.

The market size for surgical hemostats is projected to cross USD 45 billion by the end of 2036 expanding at a CAGR of 12% through 2036.

The major players in the market are Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, Pfizer Inc., CryoLife, Inc., C.R. Bard, Inc., Integra LifeSciences Corporation, Z-Medica, LLC, Cardinal Health, Inc., and others.

In terms of end-user, the hospitals segment is anticipated to account for the largest market share of 50% during 2024-2036.

The North American surgical hemostats sector is poised to hold the highest share of 35% by 2036.
Surgical Hemostats Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying